8-K Announcements
6Material company update
May 14, 2026·SEC
Material company update
May 13, 2026·SEC
Material company update
May 13, 2026·SEC
Health In Tech, Inc.(HIT)Earnings, Financials & Key Ratios
HIT•NASDAQ
$1.04
52.0× P/E·Price updated Jun 27, 2026
AboutHealth In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small to medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.Show more
- Revenue$33M+71.0%
- EBITDA$2M+58.7%
- Net Income$1M+90.7%
- EPS (Diluted)0.02+62.6%
- Gross Margin62.82%-20.7%
- EBITDA Margin7.29%-7.2%
- Operating Margin4.59%-9.7%
- Net Margin3.84%+11.5%
- ROE8.45%+21.3%
HIT Price & Volume
Health In Tech, Inc. (HIT) stock price & volume — 10-year historical chart
Loading chart...
Rapid Revenue Scaling Pressures Operating Profitability Margins
Investment Thesis • Updated 2026Q1
VerdictNeutral
Growth:Expanding
Profitability:Strained
Financial Position:Adequate
Cash Flow:Deteriorating
Primary Risk:Margin compression from scaling
"Health In Tech is currently navigating a high-growth phase driven by its eDIYBS quoting engine, yet the firm faces significant headwinds as operating margins have compressed to -24.6% in 2026Q1. While the company maintains a clean balance sheet with a debt-to-equity ratio of only 0.01, the transition toward a more complex corporate structure and rising claims advocacy costs threaten long-term profitability. Investors should monitor whether the firm can achieve operating leverage and stabilize its free cash flow, which currently sits at a -42.0% margin, before committing capital to this volatile software-application play."
Verdict Logic
while the company exhibits strong top-line growth, the shift to a -24.6% operating margin and negative free cash flow suggests that the current business model requires further maturation before it can reliably generate shareholder value.
HIT Growth Metrics
Health In Tech, Inc. (HIT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years79.42%
TTM52.29%
Profit CAGR
10 Years-
5 Years-
3 Years152.18%
TTM-175.62%
EPS CAGR
10 Years-
5 Years-
3 Years137.13%
TTM-196.95%
Return on Capital
10 Years21.01%
5 Years21.01%
3 Years26.5%
Last Year9.68%
HIT Recent Earnings
Health In Tech, Inc. (HIT) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 0/12 qtrs (0%)●Beat Revenue 4/12 qtrs (100%)
Q2 2026Latest
May 13, 2026Metric
Actual
Est
EPS
$0.03-12.5%
$0.03
Rev
$9M+18.1%
$7M
Q2 2026
Mar 25, 2026Metric
Actual
Est
EPS
$0.01+0.0%
$0.01
Rev
$8M+3.4%
$7M
Q4 2025
Nov 10, 2025Metric
Actual
Est
EPS
$0.01+0.0%
$0.01
Rev
$8M+16.7%
$7M
Q3 2025
Jul 21, 2025Metric
Actual
Est
EPS
$0.01+0.0%
$0.01
Rev
$9M+24.3%
$7M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 13, 2026 | $0.03vs $0.03-12.5% | $9Mvs $7M+18.1% |
| Q2 2026 | Mar 25, 2026 | $0.01vs $0.01+0.0% | $8Mvs $7M+3.4% |
| Q4 2025 | Nov 10, 2025 | $0.01vs $0.01+0.0% | $8Mvs $7M+16.7% |
| Q3 2025 | Jul 21, 2025 | $0.01vs $0.01+0.0% | $9Mvs $7M+24.3% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Health In Tech, Inc. (HIT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.04 | $55.98M | 52.00 | 70.99% | 3.84% | 8.45% | — | |
| $33.94 | $7.45B | 66.55 | 59% | -0.56% | -2.48% | — | |
| $2.80 | $970.56M | 32.83 | 0.57% | 3.74% | 4.75% | — | |
| $5.44 | $978.5M | -27.20 | 40.48% | -22.75% | -33.53% | — | |
| $29.79 | $7.72B | -17.63 | 27.5% | -0.3% | -3.26% | — | |
| $2.13 | $1.36B | -7.10 | -3.97% | -5.62% | -2.81% | — |
Compare HIT vs Peers
Health In Tech, Inc. (HIT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
HIT SEC Filings & Documents
Health In Tech, Inc. (HIT) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when HIT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
HIT Frequently Asked Questions
Health In Tech, Inc. (HIT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Health In Tech, Inc.'s revenue?
Health In Tech, Inc. (HIT) reported $34.1M in revenue for fiscal year 2025. This represents a 491% increase from $5.8M in 2022.
How fast is Health In Tech, Inc. growing?
Health In Tech, Inc. (HIT) grew revenue by 71.0% over the past year. This is strong growth.
Is HIT profitable?
Health In Tech, Inc. (HIT) reported a net loss of $0.8M for fiscal year 2025.
Dividend & Returns
What is HIT's return on equity?
Health In Tech, Inc. (HIT) has a return on equity (ROE) of 8.4%. This is below average, suggesting room for improvement.
What is Health In Tech, Inc.'s free cash flow?
Health In Tech, Inc. (HIT) had negative free cash flow of $1.2M in fiscal year 2025, likely due to heavy capital investments.